Mohammad Reza Sepand
Overview
Explore the profile of Mohammad Reza Sepand including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
279
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Raoufi E, Hosseini F, Onagh B, Salehi-Shadkami M, Mehrali M, Mohsenzadegan M, et al.
Clin Chim Acta
. 2023 Mar;
542:117279.
PMID: 36871661
Background: More than 3 y into the coronavirus 2019 (COVID-19) pandemic, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to undergo mutations. In this context, the Receptor Binding Domain (RBD)...
2.
Gharighnia S, Omidi A, Kashani I, Sepand M, Pour Beiranvand S
Int J Neurosci
. 2022 Aug;
134(4):409-419.
PMID: 35912879
Aim: Multiple sclerosis (MS) is the most common chronic inflammatory demyelinating disease of the central nervous system. Oxidative stress distinct pathobiological pathways plays a pivotal role in the formation and...
3.
Bigdelou B, Sepand M, NajafiKhoshnoo S, Tavares Negrete J, Sharaf M, Ho J, et al.
Front Immunol
. 2022 Jun;
13:890517.
PMID: 35711466
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated symptoms, named coronavirus disease 2019 (COVID-19), have rapidly spread worldwide, resulting in the declaration of a pandemic. When several countries...
4.
Sepand M, Bigdelou B, Ho J, Sharaf M, Lannigan A, Sullivan I, et al.
Antibodies (Basel)
. 2022 Jun;
11(2).
PMID: 35645208
Questions and concerns regarding the efficacy and immunogenicity of coronavirus disease 2019 (COVID-19) vaccines have plagued scientists since the BNT162b2 mRNA vaccine was introduced in late 2020. As a result,...
5.
Ho J, Sepand M, Bigdelou B, Shekarian T, Esfandyarpour R, Chauhan P, et al.
Immunology
. 2022 Apr;
166(4):429-443.
PMID: 35470422
The coronavirus disease 2019 (COVID-19) pandemic has created unprecedented challenges worldwide. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19 and has a complex interaction with the immune system, including...
6.
Sepand M, Salek Maghsoudi A, Shadboorestan A, Mirnia K, Aghsami M, Raoufi M
Life Sci
. 2021 Jul;
281:119799.
PMID: 34229007
Despite numerous studies on the mechanisms of cigarette smoking toxicity over the past three decades, some aspects remain obscure. Recent developments have drawn attention to some hopeful indicators that allow...
7.
Pakzad D, Akbari V, Sepand M, Aliomrani M
Toxicol Res (Camb)
. 2021 Apr;
10(2):325-333.
PMID: 33884182
It is estimated that around 140 million people are drinking highly contaminated water with arsenic (As) as a natural earth's crust component. On the other hand, the prevalence of neurodegenerative...
8.
Sepand M, Aghsami M, Keshvadi M, Bigdelou B, Behzad R, Zanganeh S, et al.
Environ Res
. 2021 Mar;
196:110933.
PMID: 33689818
Macrophages are a critical member of the innate immune system and can intensify tumor invasiveness and assist the growth of neoplastic cells. Moreover, they have the capability to reinforce immunosuppression...
9.
Sepand M, Ranjbar S, Kempson I, Akbariani M, Muganda W, Muller M, et al.
Nanomedicine
. 2020 Jul;
29:102243.
PMID: 32623018
Many tumors develop resistance to most of the apoptosis-based cancer therapies. In this sense targeting non-apoptotic forms of cell death including necroptosis, autophagy and ferroptosis may have therapeutic benefits in...
10.
Shamsian A, Sepand M, Kachousangi M, Dara T, Ostad S, Atyabi F, et al.
Int J Nanomedicine
. 2020 Jul;
15:4063-4078.
PMID: 32606664
Background: Among various theories for the origin of cancer, the "stemness phenotype model" suggests a dynamic feature for tumor cells in which non-cancer stem cells (non-CSCs) can inter-convert to CSCs....